Moody Aldrich Partners’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,940
Closed -$232K 210
2025
Q4
$232K Sell
3,940
-7
-0.2% -$425 0.04% 177
2025
Q3
$220K Buy
+3,947
New +$211K 0.04% 177
2025
Q1
Sell
-3,984
Closed -$287K 214
2024
Q4
$287K Sell
3,984
-17
-0.4% -$1.25K 0.05% 168
2024
Q3
$320K Buy
4,001
+5
+0.1% +$376 0.06% 155
2024
Q2
$286K Sell
3,996
-2,459
-38% -$181K 0.06% 172
2024
Q1
$454K Buy
6,455
+104
+2% +$7.44K 0.08% 148
2023
Q4
$490K Buy
6,351
+2,576
+68% +$170K 0.09% 131
2023
Q3
$257K Buy
+3,775
New +$298K 0.05% 170
2023
Q2
Sell
-6,726
Closed -$499K 178
2023
Q1
$499K Sell
6,726
-11
-0.2% -$848 0.1% 119
2022
Q4
$558K Sell
6,737
-99
-1% -$7.86K 0.11% 124
2022
Q3
$485K Hold
6,836
0.1% 120
2022
Q2
$592K Sell
6,836
-60
-0.9% -$5.62K 0.12% 105
2022
Q1
$747K Buy
6,896
+1,672
+32% +$173K 0.11% 105
2021
Q4
$676K Sell
5,224
-72
-1% -$8.83K 0.09% 117
2021
Q3
$642K Sell
5,296
-4
-0.1% -$487 0.08% 126
2021
Q2
$597K Sell
5,300
-80
-1% -$8.42K 0.08% 127
2021
Q1
$514K Buy
5,380
+872
+19% +$79.6K 0.07% 139
2020
Q4
$358K Sell
4,508
-24
-0.5% -$1.74K 0.06% 139
2020
Q3
$281K Sell
4,532
-320
-7% -$20.8K 0.06% 135
2020
Q2
$320K Sell
4,852
-280
-5% -$16.8K 0.07% 136
2020
Q1
$243K Sell
5,132
-24
-0.5% -$1.2K 0.07% 125
2019
Q4
$283K Buy
+5,156
New +$271K 0.06% 131
2019
Q3
Sell
-6,652
Closed -$347K 139
2019
Q2
$347K Sell
6,652
-912
-12% -$46K 0.09% 110
2019
Q1
$375K Sell
7,564
-24
-0.3% -$1.08K 0.11% 92
2018
Q4
$275K Sell
7,588
-1,260
-14% -$52.6K 0.09% 84
2018
Q3
$451K Sell
8,848
-480
-5% -$21.3K 0.13% 89
2018
Q2
$345K Buy
9,328
+1,032
+12% +$39.4K 0.12% 87
2018
Q1
$313K Buy
+8,296
New +$293K 0.2% 80

Other funds holding TECH

Moody Aldrich Partners's TECH Position: Q1 2026 in Review

Moody Aldrich Partners sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 3,940 shares — an estimated $232K sold.

Moody Aldrich Partners first reported a position in TECH in Q1 2018 and held it in 28 quarters. The position peaked at $747K in Q1 2022. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Moody Aldrich Partners reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Moody Aldrich Partners sold 3,940 Bio-Techne shares in Q1 2026, an estimated $232K.
  • Moody Aldrich Partners first reported a position in Bio-Techne in Q1 2018 and held it in 28 quarters.
  • Moody Aldrich Partners's Bio-Techne position peaked at $747K in Q1 2022.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Moody Aldrich Partners's 13F filing for Q1 2026, filed 20 Apr 2026.